Send feedback

ENG p.Ala425=

c.1275G>A · rs963830488 · VCV1591820

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00534%, afr)
Conditions
1
hereditary hemorrhagic telangiectasia

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal.
Splicing
SpliceAIΔ0.20acceptor gain · deltas
Constraint at this position
ConservationphyloP 1.3GERP -0.46, phastCons 0.97
Overall
CADD15.87PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00534% African / African-American · 4/74,916 alleles
Filtering AF 0.00175% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00104%
Overall 0.00137% 22/1,609,626 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0136% 7,366
African / African-Americangrpmax 0.00534% 18,729
Remaining individualsnot grpmax-eligible 0.0016% 62,350
European (non-Finnish) 0.0011% 90,624

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ENG
Protein
p.Ala425=
Coding
c.1275G>A
MANE Select
NM_001114753
dbSNP
rs963830488
Type
single nucleotide variant
Location
chr9:127819658 (GRCh38)
Gene constraint
LOEUF 0.374 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 80.84 · 3 PDB
Residue 425
a β-strand; a disulfide bond; the zp domain
Full ENG gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary hemorrhagic telangiectasia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary hemorrhagic telangiectasia (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eng-p-ala425 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown